Genome
Business Services · South Korea · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Korea Bio Park B 901 Daewangpangyo-ro Bu...Phone Number
+82 316280150Website
www.genomecom.co.krRevenue
$5.4 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Genome
Genome & Company is a publicly traded (KRX: 314130), clinical-stage biotechnology company based in Seongnam, Republic of Korea that focuses on discovering and developing the next waves of innovative therapeutics in immuno-oncology through diverse modalities of microbiome, novel target immune checkpoint inhibitors and fusion proteins to fulfill the unmet needs of cancer patients.Explore more
Genome Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Genome your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Genome
Genome, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Genome is spiking on competitors!
Check if Genome has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Genome launches new products
Earning: See what the market has to say on Genome recently announced quarterly report
Click to see if Genome had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Genome has new funding data
Recommended Actions
Reach out to Masked Content who joined Genome as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Genome is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Genome is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Genome.
Genome financials insights
Gather financial insights about Genome, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Series A
$3M
Series B
$26.5M
Genome Tech Stack
A closer look at the technologies used by Genome
Genome News & Media
Debiopharm and Genome & Company Reach Agreement for Potential First-In Class Oncology Antibody Drug Conjugate Family
LAUSANNE, Switzerland & SUWON-SI GYEONGGI-DO, South Korea--(BUSINESS WIRE)--Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based, biopharmaceutical company aiming to establish tomorrow’s standard-of-care to cure cancer and infectious diseases, today announced the signing of an exclusive licensing agreement with Genome & Company (http://genomecom.co.kr/), a publicly-traded, South Korea-based, biotechnology company focusing on discovery and development of novel target antibody therGenome and Company announces Clinical Trial Collaboration with MSD to evaluate 'GEN-001' in combination of KEYTRUDA® (pembrolizumab) in phase 2 clinical trial in biliary tract cancer patients
SEOUL, South Korea, March 3, 2022 /PRNewswire/ -- Genome and Company (KOSDAQ: 314130, CEO∙CTO: Jisoo Pae∙Hansoo Park), a leading global microbiome anti-cancer drug development company, announced it has entered into a first Clinical Trial Collaboration and Supply Agreement (CTCSA) with MSD...List Biotherapeutics Establishes New Microbiome Manufacturing Facility in Fishers
FISHERS, Ind.--(BUSINESS WIRE)-- #biotech--List Biotherapeutics Establishes New Microbiome Manufacturing Facility in FishersScioto Biosciences, Inc. Announces First Patient Dosed in Phase Ib Study in Patients Diagnosed with Autistic Disorder
INDIANAPOLIS--(BUSINESS WIRE)--Scioto Biosciences announces first patient dosed in Phase Ib trial in patients diagnosed with Autistic Disorder.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Genome
Sign Up For FreeTo access detailed company insights
Genome & Company is a publicly traded (KRX: 314130), clinical-stage biotechnology company based in Seongnam, Republic of Korea that focuses on discovering and developing the next waves of innovative therapeutics in immuno-oncology through diverse modalities of microbiome, novel target immune checkpoint inhibitors and fusion proteins to fulfill the... Read More
